Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
-
Published:2021-03-05
Issue:9
Volume:124
Page:1552-1555
-
ISSN:0007-0920
-
Container-title:British Journal of Cancer
-
language:en
-
Short-container-title:Br J Cancer
Author:
Thomson Amanda, Bento Diana F. Costa, Scurr Martin J.ORCID, Smart Kathryn, Somerville Michelle S., Keita Åsa V., Gallimore Awen, Godkin Andrew
Abstract
Abstract
Background
The T cell cytokine profile is a key prognostic indicator of post-surgical outcome for colorectal cancer (CRC). Whilst TH1 (IFN-γ+) cell-mediated responses generated in CRC are well documented and are associated with improved survival, antigen-specific TH17 (IL-17A+) responses have not been similarly measured.
Methods
We sought to determine the cytokine profile of circulating tumour antigen-(5T4/CEA) specific T cells of 34 CRC patients to address whether antigen-specific IL-17A responses were detectable and whether these were distinct to IFN-γ responses.
Results
As with IFN-γ-producing T cells, anti-5T4/CEA TH17 responses were detectable predominantly in early stage (TNM I/II) CRC patients. Moreover, whilst IL-17A was always produced in association with IFN-γ, this release was mainly from two distinct T cell populations rather than by ‘dual producing’ T cells. Patients mounting both tumour-specific TH1+/TH17+ responses exhibited prolonged relapse-free survival.
Conclusions
Tumour antigen-specific TH17 responses play a beneficial role in preventing post-operative colorectal tumour recurrence.
Funder
Cancer Research Wales Cancer Research UK
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference11 articles.
1. Scurr, M. J., Brown, C. M., Costa Bento, D. F., Betts, G. J., Rees, B. I., Hills, R. K. et al. Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer. J. Natl. Cancer Inst. 107, djv001 (2015). 2. Tosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G. et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res. 71, 1263–1271 (2011). 3. Parkhurst, M. R., Yang, J. C., Langan, R. C., Dudley, M. E., Nathan, D. A., Feldman, S. A. et al. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol. Ther. 19, 620–626 (2011). 4. Hurtado, C. G., Wan, F., Housseau, F. & Sears, C. L. Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer. Gastroenterology 155, 1706–1715 (2018). 5. Amicarella, F., Muraro, M. G., Hirt, C., Cremonesi, E., Padovan, E., Mele, V. et al. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. Gut 66, 692–704 (2017).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|